End-of-day quote
Other stock markets
|
||
- USD | - |
|
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from S&P TMI Index | CI |
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from NASDAQ Composite Index | CI |
Sales 2016 | 0.14 12.1 | Sales 2017 | - | Capitalization | 2.29Cr 190.77Cr |
---|---|---|---|---|---|
Net income 2016 | -5.5Cr -459.14Cr | Net income 2017 | -2.6Cr -217.05Cr | EV / Sales 2016 | 4,40,69,434 x |
Net cash position 2016 | 2.08Cr 174Cr | Net cash position 2017 | 21.96L 18Cr | EV / Sales 2017 | - |
P/E ratio 2016 |
-0.4
x | P/E ratio 2017 |
-0.58
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+16.61% | 12TCr | |
+17.75% | 11TCr | |
+17.23% | 2.59TCr | |
-24.11% | 1.93TCr | |
-18.56% | 1.62TCr | |
-18.47% | 1.56TCr | |
-47.75% | 1.46TCr | |
+57.35% | 1.43TCr | |
+5.62% | 1.4TCr |